Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Obese Adults With Type-2 Diabetes
Conditions
Interventions
BMS-986036
Placebo (Matching with BMS-986036)
Locations
16
United States
Arkansas Clinical Research
Little Rock, Arkansas, United States
Anaheim Clinical Trials Llc
Anaheim, California, United States
National Research Institute
Los Angeles, California, United States
Encompass Clinical Research
Spring Valley, California, United States
Encompass Clinical Research
Spring Valley, California, United States
All Medical Research, Llc
Cooper City, Florida, United States
Start Date
April 15, 2014
Primary Completion Date
September 22, 2015
Completion Date
May 17, 2016
Last Updated
July 31, 2019
NCT06525259
NCT05934409
NCT07011147
NCT03821636
NCT06957093
NCT07250789
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions